Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells

For many tumor types chemotherapy still represents the therapy of choice and many standard treatments are based on the use of platinum (PT) drugs. However, de novo or acquired resistance to platinum is frequent and leads to disease progression. In Epithelial Ovarian Cancer (EOC) patients, PT-resista...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Ranzuglia, Valentina, Lorenzon, Ilaria, Pellarin, Ilenia, Sonego, Maura, Dall’Acqua, Alessandra, D’Andrea, Sara, Lovisa, Sara, Segatto, Ilenia, Coan, Michela, Polesel, Jerry, Serraino, Diego, Sabatelli, Patrizia, Spessotto, Paola, Belletti, Barbara, Baldassarre, Gustavo, Schiappacassi, Monica
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529585/
https://ncbi.nlm.nih.gov/pubmed/32848212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01433-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados